• Agreement outlines an exclusive patent license granted to Wellgistics Health, giving the company sole access within its market segment to Datavault AI’s proprietary technologies.
• At the center of the initiative is PharmacyChain(TM), a platform designed to track and manage prescription fulfillment from manufacturer to patient while automating processes that are traditionally routed through PBMs.
• By granting exclusive, Datavault AI creates a stronger commercial incentive for adoption while also reinforcing the value of its intellectual property portfolio.

Prescription drug prices in the United States are among the highest in the world, driven in part by complex rebate structures controlled by pharmacy benefit managers (“PBMs”). Datavault AI (NASDAQ: DVLT), a technology company focused on AI-driven data monetization and digital asset infrastructure, is entering this landscape through an exclusive licensing agreement with Wellgistics Health Inc. The agreement positions the company’s technology at the center of a platform designed to streamline prescription distribution and reduce reliance on traditional intermediaries.

According to the company, the agreement outlines an exclusive patent license granted to Wellgistics Health, giving the company sole access within its market segment to Datavault AI’s proprietary technologies. This exclusivity is a defining feature of the agreement, as it prevents direct…

Read More>>

NOTE TO INVESTORS: The latest news and updates relating to DVLT are available in the company’s newsroom at https://ibn.fm/DVLT

About DefenseWireNews

DefenseWireNews (“DWN”) is a specialized communications platform with a focus on defense contractors, aerospace firms, cybersecurity leaders, advanced manufacturing innovators, and other mission-critical companies operating at the intersection of public markets and government demand. It is one of 75+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, DWN is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists, and the general public. By cutting through the overload of information in today’s market, DWN brings its clients unparalleled recognition and brand awareness. DWN is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from DefenseWireNews, text “STOCKS” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.DefenseWireNews.com

Please see full terms of use and disclaimers on the DefenseWireNews website applicable to all content provided by DWN, wherever published or re-published: https://www.DefenseWireNews.com/Disclaimer

DefenseWireNews
Austin, TX
www.DefenseWireNews.com
512.354.7000 Office
Editor@DefenseWireNews.com

DefenseWireNews is powered by IBN

This contant was orignally distributed by InvestorBrandNetwork (IBN). Blockchain Registration, Verification & Enhancement provided by NewsRamp™. The source URL for this press release is Datavault AI Inc. (NASDAQ: DVLT) Announces Exclusive Healthcare License Targeting PBM-Driven Drug Pricing Inefficiencies.